Initial results of early gastrointestinal cancer treatment using endoscopic submucosal dissection at 19-8 hospital

Autores/as

Palabras clave:

endoscopy, endoscopic submucosal dissection, gastrointestinal cancer

Resumen

Introduction: Early-stage cancer is defined as cancer confined to the mucosal or submucosal layers (T1 stage) without lymph node metastasis.

Objective: To evaluate the outcomes of endoscopic submucosal dissection in treating early-stage gastrointestinal cancer.

Methods: A prospective descriptive study involving 20 patients with early-stage gastrointestinal cancer treated using endoscopic submucosal dissection at the Gastroenterology Department of 19-8 Hospital from September 2023 to September 2024.

Results: Average procedure duration: 62-180 minutes; lesion size: 6-45mm; in bloc resection rate: 100 %; bleeding complication rate: 5 %; average hospital stay: 3-8 days; lesion locations: hypopharynx, esophagus, stomach, colon, and rectum.

Conclusions: Endoscopic submucosal dissection is an effective and relatively safe technique for treating early-stage cancer. Complications such as perforation and bleeding can occur but are manageable. Endoscopic submucosal dissection allows for en bloc lesion removal, enabling pathologists to accurately assess resection margins through histopathological results. During endoscopy, careful observation is necessary to avoid missing lesions, especially when the scope passes through the stimulated hypopharynx.

Publicado

2024-12-19

Cómo citar

1.
Thanh Tuyen H, Viet Dung N, Viet Anh PT, Phuong Thao DT, Duc Pham V, Van Khanh HT, et al. Initial results of early gastrointestinal cancer treatment using endoscopic submucosal dissection at 19-8 hospital. Invest Medicoquir [Internet]. 19 de diciembre de 2024 [citado 5 de diciembre de 2025];16(1):e933. Disponible en: https://revcimeq.sld.cu/index.php/imq/article/view/933

Número

Sección

Comunicación breve